| Literature DB >> 27912680 |
Johnathan Ng1, Kara Spiller2, Jonathan Bernhard1, Gordana Vunjak-Novakovic1,3.
Abstract
Although autologous bone grafts are considered a gold standard for the treatment of bone defects, they are limited by donor site morbidities and geometric requirements. We propose that tissue engineering technology can overcome such limitations by recreating fully viable and biological bone grafts. Specifically, we will discuss the use of bone scaffolds and autologous cells with bioreactor culture systems as a tissue engineering paradigm to grow bone in vitro. We will also discuss emergent vascularization strategies to promote graft survival in vivo, as well as the role of inflammation during bone repair. Finally, we will highlight some recent advances and discuss new solutions to bone repair inspired by endochondral ossification.Entities:
Keywords: biomimetics; bone; tissue engineering
Mesh:
Year: 2017 PMID: 27912680 PMCID: PMC5653138 DOI: 10.1089/ten.TEB.2016.0289
Source DB: PubMed Journal: Tissue Eng Part B Rev ISSN: 1937-3368 Impact factor: 6.389